ResultsMoneycontrol
Alkem Labs Q2 net profit falls 14% to Rs 667 crore
GreyOak summary
Alkem Laboratories reported a 14.37% decline in consolidated net profit to Rs 667.13 crore for the September quarter due to higher expenses, despite revenue rising to Rs 4,551.99 crore. The company's India business grew 9.5% while international revenue increased 22.3%. Shares declined 3% on the announcement, with brokerages divided on the growth outlook amidst margin pressures from new investments.
What it affects
- Alkem LaboratoriesALKEMNegative -66
Net profit fell 14% to Rs 667 croreRolling sentiment Negative -52
Source
Read the original at MoneycontrolMore Alkem Laboratories news
- Alkem shares fall 3% after Q2 results; MOFSL retains Neutral ratingBusiness Standard · Results ·
- Motilal Oswal sets ALKEM target at Rs 5890Moneycontrol · Company update ·
- Alkem shares decline 2% as HSBC maintains Hold ratingMoneycontrol · Company update ·
- Alkem PAT down at ₹675 crore; biotech sales down 37%BusinessLine · Results ·
- Alkem Labs Q2 revenue rises 14%, profit fallsCNBC-TV18 · Results ·